BioCentury

7:00 AM GMT, Aug 13, 2007
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 8/10 cls
Acadia (ACAD) Piper Jaffray Edward Tenthoff Price target Market outperform 10% $16.40
Tenthoff raised his target to $23 from $21 after the company's 2Q07 earnings showed an R&D spend of $10.8M, below his $13M estimate. Also, this year he expects the

Read the full 547 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.